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Vitamin D deficiency causes metabolic bone 
disease and increases the risk of many common 
chronic diseases (1). Adequate vitamin D sta-
tus is important for optimal function of many 
organs and tissues of our body, including car-
diovascular system (2). Vitamin D deficiency 
has been found to be associated with dyslipi-
daemia, cardiovascular diseases (CVDs), and 
mortality (3-6).
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ABSTRACT
Elevated total cholesterol and low-density lipoprotein cholesterol in sera are both well-known risk fac-
tors of coronary heart disease. Adequate vitamin D status is important for optimal function of many 
organs and tissues of our body. There is continuing controversy about the effect of adequate vitamin 
D consumption on serum lipids and lipoproteins. The present study assessed the effect of vitamin 
D, calcium and multiple micronutrients supplementation on the lipid profile in Bangladeshi young 
female garment factory workers who have hypovitaminosis D. This placebo-controlled intervention 
trial conducted over a period of one year randomly assigned a total of 200 apparently healthy subjects 
aged 16-36 years to 4 groups. The subjects received daily supplements of 400 IU of vitamin D (VD 
group) or 400 IU of vitamin D+600 mg of calcium lactate (VD-Ca group), or multiple micronutrients 
with 400 IU of vitamin-D+600 mg of calcium lactate (MMN-VD-Ca group), or the group consuming 
placebo (PL group). Serum concentrations of lipid and lipoprotein, 25-hydroxyvitamin D (25OHD) 
and intact parathyroid hormone (iPTH) were measured at baseline and after one year of follow-up. No 
significant changes in the serum levels of total cholesterol (TC), low-density lipoprotein cholesterol 
(LDL-C), high-density lipoprotein cholesterol (HDL-C), LDL-C/HDL-C ratio were observed in the sup-
plemented groups compared to the placebo group. Supplementation had a positive effect (p<0.05) on 
very low-density lipoprotein cholesterol (VLDL-C) and triacylglycerol (TAG). A negative correlation 
between changes in serum iPTH and HDL-C was observed, which indicated that subjects with the 
greatest decline in S-iPTH had the greatest increase in HDL-C. The results suggest that consumption 
of adequate vitamin D with calcium or MMN for one-year may have no impact on serum lipid profile 
in the subjects studied. Longer-term clinical trials with different doses of supplemental vitamin D are 
warranted in evaluating the effect of intervention.
Key words: Female garment workers; HDL-cholesterol; LDL-cholesterol; Total cholesterol; Triacylglycerol; 
Vitamin D intervention; Bangladesh
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Elevated total cholesterol (TC) and low-density li-
poprotein cholesterol (LDL-C) in the sera are both 
well-known risk factors of coronary heart disease 
(CHD) whereas elevated concentrations of high-
density lipoprotein cholesterol (HDL-C) appear to 
protect against CHD. Increased concentrations of 
serum triglycerides are also associated with an in-
creased risk of CHD (7). Obesity and type 2 diabetes 
occur at epidemic rates globally and atherosclerotic 
CVD remains one of the leading causes of mortal-
ity and morbidity (8). Recent epidemiological data 
suggested that subjects with serum 25OHD levels 
of ≥75 nmol/L had a 6.1-fold reduced risk of in-
cident hypertension compared to vitamin D de-
ficient (serum 25OHD level <35 nmol/L) subjects 
(9). One probable explanation could be the effect 
of vitamin D on serum lipids, one of the major risk 
factors of CVD, or vitamin D is a vaso-active agent 
and may play a protective role in the development 
of atherosclerosis. 
However, based on the intervention trials, the 
available data do not support unanimously the ef-
fect of adequate vitamin D supplementation on se-
rum lipids. Only limited data suggested that CVD 
risks could be reduced with vitamin D supplements 
at moderate to high doses and the investigators 
stressed further research in this field (10,11). In 
fact, data are scarce about the impact of adequate 
vitamin D consumption—whether supplementa-
tion with vitamin D would improve cardiovascular 
risk factors is not studied extensively. This study 
assessed the effect of vitamin D, calcium and mul-
tiple micronutrients supplementation on serum 
lipids and lipoproteins in a representative sample 
of Bangladeshi low-income pre-menopausal female 
garment workers with hypovitaminosis D. 
MATERIALS AND METHODS
Study setting and subjects
The study site was an export-oriented garment fac-
tory located at Mirpur in Dhaka city, belonging 
to Standard Group Bangladesh. The participants 
were mainly young women from low-income rural 
families, who had migrated to the city for employ-
ment at least two years earlier. Subjects lived in an 
underdeveloped area in low-cost accommodation. 
They worked dawn to dusk, 7 days a week. The eli-
gibility criteria for inclusion of subjects comprised: 
no history of serious diseases, no history of medi-
cation known to affect bone metabolism, no cur-
rent pregnancies, no lactation within the previous 
three years, and residing in the city for at least two 
years. The fieldworkers explained the objectives of 
the study to the subjects in an understandable way. 
Written informed consent was obtained from both 
interested subjects and the authority of the gar-
ment factory before initiating the study. The study 
protocol was approved by the Ethical Committee 
of the Faculty of Agriculture and Forestry, Univer-
sity of Helsinki. During the field study in Bangla-
desh, we also followed the ethical guidelines of the 
University of Dhaka.
Study design
The study comprised a one-year, placebo-controlled, 
randomized intervention trial. The assigned 200 
subjects met all of the inclusion criteria. Partici-
pants were randomly assigned to one of the four 
groups with blocks of equal size after their eligibil-
ity criteria had been fulfilled. Randomization was 
carried out by a person who was not involved in 
the project. The subjects were provided with daily 
supplements of 400 IU of vitamin D (VD group), 
400 IU of vitamin D+600 mg of calcium as calci-
um-lactate (VD-Ca group), multiple micronutrients 
with 400 IU of vitamin D+600 mg of calcium as 
calcium-lactate (MMN-VD-Ca group), or a placebo 
(placebo group). The recruitment and randomiza-
tion processes are presented in Figure 1. A total of 
50 subjects in each group were selected for supple-
mentation. The number of subjects who completed 
intervention in different groups were: VD (n=40), 
VD-Ca (n=41), MMN-VD-Ca (n=37) and Placebo 
(n=35). The total dropout percentage was 23.5. 
The compositions of supplements comprising oral 
calcium tablets (‘G-Calcium’ from Gonoshasthaya 
Pharmaceuticals Ltd), MMN tablets (‘Aristovit M’ 
from Beximco Pharmaceuticals Ltd., Bangladesh, 
containing 15 micronutrients) and vitamin D tab-
lets (‘Minisun’ from Oy Verman AB, Jarvenpaa, Fin-
land) are presented elsewhere (12). Both calcium 
and vitamin D placebos were donated by the same 
companies and were identical to the active tablets.
Subjects received their supplements daily from the 
field assistants for 12 months. The field assistants 
arrived at the garment factory every day (7 days a 
week) before the lunch break. Tablets were given 
to the subjects during their lunch break, inside the 
garment factory, under close observation of the 
field assistants. The field assistants always ensured 
that the tablets were swallowed with a glass of wa-
ter and maintained a written daily record of supple-
ment consumption by each subject. In case a sub-
ject was absent from work, supplements were given 
to their colleagues to deliver to their co-workers for 
consumption in the evening at home. 
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Laboratory measurements
Blood samples were collected between 8:30 and 
10:00 am after an overnight fasting. Five mL of ve-
nous blood were drawn using disposable syringes. 
The serum was separated and preserved at -20 °C. 
Finally, the serum samples were transported to 
Helsinki in a special container with dry ice and 
preserved in the freezing room of the Division of 
Nutrition, Department of Food and Environmen-
tal Sciences, University of Helsinki, at -20 °C until 
analysis.
Serum total cholesterol (TC), high-density lipopro-
tein cholesterol (HDL-C), and triacylglycerol (TAG) 
were measured with an automated KoneLab spec-
trophotometer (Thermo Clinical Labsystems Ltd., 
Espoo, Finland), using routine methods. The 
Figure 1. Flowchart of the number of subjects recruited and dropping out: VD, VD-Ca, and
                MMN-VD-Ca
Female garment workers aged 18-36 years were screened based on
selection criteria at the Standard Garment Factory, Mirpur, Dhaka
(N=236 )
First visit: Background, anthropometric data, and blood samples 
(n=200)
No longer willing to 
participate (n=19),
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concentration of serum VLDL-C was calculated 
by using the equation VLDL-C=TAG×0.45 and 
the concentration of serum LDL-C by using the 
equation LDL-C=TC–HDL-C–VLDL-C. Serum 25-
hydroxyvitamin D was used in evaluating vitamin 
D status. The concentration was determined by the 
enzyme-immunoassay method with kits from OC-
TEIA (IDS, Boldon, UK). The laboratory is a part-
ner of the Vitamin D External Quality Assessment 
Scheme (DEQAS, www.DEQAS.org.uk). The intra-
and inter-assay CVs were 5.4% and 7.0% respec-
tively. Serum intact parathyroid hormone (S-iPTH) 
level was measured with a commercial two-site im-
munoenzymometric assay (OCTEIA, IDS, Boldon, 
UK), with 10-65 ng/L as a reference range. Intra- 
and inter-assay CVs for S-iPTH were 3.5% and 5.6% 
respectively. The laboratory analysis was carried 
out at the Department of Food and Environmental 
Sciences, University of Helsinki. The vitamin D de-
ficiency, insufficiency, and sufficiency were defined 
as S-25OHD levels of <50 nmol/L, 50-75 nmol/L, 
and >75 nmol/L respectively. The secondary hyper-
parathyroidism was defined as S-iPTH levels of >65 
ng/L. All measurements were taken at baseline and 
after 12 months of follow-up. The study was con-
ducted from April 2004 to April 2005. 
Other data
Anthropometric, socioeconomic and background 
data were collected at baseline and after one year of 
follow-up. A questionnaire was used for obtaining 
information on monthly income, level of educa-
tion, age at menarche, duration of residence in the 
city, daily time spent outdoors, etc. Standing height 
was measured with a wall-mounted scale to the 
nearest 0.5 cm. Body-weight was measured without 
shoes and with light clothing on a portable weigh-
ing scale to the nearest 0.5 kg. We used the clas-
sifications of body mass index (BMI) [weight (kg)/
height (m)2] recommended by the World Health 
Organization (13).
Statistical analysis
Statistical analyses were carried out with SPSS (ver-
sion 15.0) for Windows (SPSS, Chicago, IL, USA). 
The normal distribution of variables was assessed 
with a Kolmogorov-Smirnov test. If normality was 
not present, logarithmic transformations were 
made before further analysis. Serum lipid data and 
other selected variables were tested with both 
ANOVA and ANCOVA to show the effect of con-
founding factors. Covariates were also noted in each 
analysis. The post-hoc analyses were performed 
with Tukey’s Honestly Significant Different (HSD) 
test and Dunnett’s test. A multiple linear regression 
model with age, BMI, serum calcium, serum iPTH, 
and creatinine as covariates was used in evaluating 
S-25OHD as an individual predictor of serum lipids 
and lipoproteins. Correlations were evaluated with 
Pearson’s correlations coefficient—r. All data are re-
ported as means±standard deviations; p<0.05 was 
considered significant.
RESULTS
A total of 153 subjects completed the one-year in-
tervention trial out of 200 subjects selected at the 
baseline, and 23.5% of the participants (47 sub-
jects) dropped out for some reasons not related to 
the study. The number of subjects at various stages 
is shown in Figure 1. We observed no significant 
changes in socioeconomic status, level of educa-
tion, physical activity, lifestyle, daily time spent 
outdoors in the sunshine, and most anthropo-
metric characteristics between the supplemented 
groups at baseline and after supplementation (all 
data not shown). No significant group difference 
was present with respect to BMI both at baseline 
and post-supplementation. A summary of the base-
line descriptive, biochemical characteristics of the 
study population completing the trial is shown in 
Table 1. 
There was no significant difference in serum lipid 
status among placebo and supplemented groups 
at baseline. More than 92% of the subjects had 
serum T-C <5.0 mmol/L at baseline, which is gener-
ally considered the borderline higher limit of de-
sired range. Serum T-C levels of >5.0 mmol/L were 
observed in 12 subjects in four groups—three in 
the placebo group, six in the VD group, two in the 
VD-Ca group, and one in the MMN-VD-Ca group. 
We observed that 99% of the subjects in random-
ly-assigned groups had very low HDI-C level (<1.0 
mmol/L) and the prevalence of low HDI-C level 
was not changed significantly even after one year 
of supplementation. 
No significant (p>0.05) group differences were 
observed between the four groups both at base-
line and after 12 months of follow-up with re-
spect to serum T-C, LDL-C, HDL-C, and LDL-C/
HDL-C ratio (Table 2). There were no significant 
differences even when the combined VD, VD-
Ca and MMN-VD-Ca group was compared with 
the PL group or when analyzing separately using 
changes in S-25OHD levels as covariate (data not 
shown). We observed a significant (p<0.05) posi-
tive effect on VLDL-C and TAG after supplemen-
tation. Percentages of subjects in different groups 
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with serum lipids above and below the desirable 
range at baseline and after one year are presented 
in Table 3. 
Significantly higher S-25OHD concentrations were 
observed in the supplemented groups than in the 
placebo group (Figure 2). Supplementation had 
an effect (p<0.001) on S-iPTH in the VD-Ca and 
MMN-VD-Ca groups compared to the placebo 
group, which is presented elsewhere (12). We ob-
served a negative correlation between changes in 
serum iPTH and HDL-C. Our results indicated that 
subjects with the greatest decline in S-iPTH had the 
greatest increase in HDL-C (Figure 3). 
DISCUSSION
Vitamin D is integral to numerous physiologic 
functions in cells and tissues. Several studies re-
ported the effect of vitamin D supplementation 
on cardiovascular risk factors in elderly subjects 
(14-21). The findings of all of these studies are in-
consistent. A few studies have examined the ef-
fect of vitamin D supplementation on lipid profile 
among young women of childbearing age. The 
present study investigated the possible impact 
of vitamin D supplementation on lipid profile 
among pre-menopausal women with hypovitami-
nosis D. The study among Finnish post-menopau-
Table 1. Baseline characteristics of the randomly-assigned groups and changes from baseline characteristics 
after one year
Baseline physical and 
biochemical charac-
teristics 
Placebo (n=35) VD (n=40) VD-Ca (n=41) MMN-VD-Ca (n=37)
p value
Mean SD Mean SD Mean SD Mean SD
Age (years) 22.9 3.9 22.1 3.9 23.0 3.6 22.4 3.3 0.564
BMI (kg/m2) 21.7 2.4 22.0 2.8 21.3 3.1 21.5 2.6 0.606
HDL-C (mmol/L) 0.78 0.25 0.74 0.18 0.71 0.15 0.79 0.24 0.280
LDL-C (mmol/L) 2.24 0.82 2.30 0.70 2.29 0.54 2.27 0.58 0.543 
LDL-C/HDL-C ratio 3.31 1.10 3.25 1.22 3.38 1.13 3.12 1.31 0.450
VLDL-C (mmol/L) 0.57 0.28 0.60 0.30 0.55 0.32 0.50 0.16 0.816
TC (mmol/L) 4.00 0.96 4.00 0.86 3.86 0.73 3.79 0.63 0.598
TAG (mmol/L) 1.26 0.63 1.34 0.68 1.24 0.71 1.11 0.35 0.450
BMI=Body mass index; Ca=Calcium; HDL-C=High-density lipoprotein cholesterol; LDL-C=Low-density li-
poprotein cholesterol; MMN-VD-Ca=Multiple micronutrients-Vitamin. D-Calcium; TAG=Triacylglycerol; 
TC=Total cholesterol; VD=Vitamin D; VD-Ca=Vitamin D-Calcium




Placebo (n=35) VD (n=40) VD-Ca (n=41)
MMN-VD-Ca 
(n=37) p value
Mean SD Mean SD Mean SD Mean SD
BMI (kg/m2) -0.12 2.04 0.48 1.25 0.10 1.38 -0.06 1.49 0.324
HDL-C (mmol/L) -0.03 0.24 -0.05 0.22 0.02 0.15 -0.03 0.21 0.726†
LDL-C (mmol/L) -0.11 0.73 0.03 0.68 -0.05 0.43 -0.05 0.62 0.826
LDL-C/HDL-C ratio 0.05 1.10 0.25 0.94 -0.09 0.89 -0.04 1.08 0.364
VLDL-C (mmol/L) -0.11 0.21 0.01 0.22 0.01 0.25 0.02 0.17 0.039
T-C (mmol/L) -0.09 0.88 0.02 0.95 0.07 0.54 0.12 0.73 0.714‡
TAG (mmol/L) -0.25 0.48 -0.02 0.51 0.03 0.57 0.04 0.38 0.048¥
BMI=Body mass index; HDL-C=High-density lipoprotein cholesterol; LDL-C=Low-density lipoprotein 
cholesterol; MMN-VD-Ca=Multiple micronutrients-Calcium; TAG=Triacylglycerol; TC=Total chole-
sterol; VD=Vitamin D; VD-Ca=Vitamin D-Calcium; Mean values were not significantly different from 
those in analysis of covariance using baseline value as covariate; †p=0.726 and using baseline value and 
BMI as covariates; ‡p=0.714; Mean value was significantly different from those in analysis of covariance, 
using baseline value and BMI as covariates, p=0.048
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sal women suggested the unfavourable effect of 
vitamin D supplementation on serum lipids. The 
study observed that LDL-C significantly increased 
by 4.1% and HDL-C decreased by 5.2% with daily 
supplement of 7.5 µg of vitamin D for 3 years (16). 
On the contrary, our results did not indicate any 
beneficial (nor detrimental) effects of supplemen-
tation on serum lipid-lipoprotein concentrations 
in apparently healthy young women with hypo-
vitaminosis D. Our findings are consistent with 
several other studies on vitamin D intervention 
that continued for one year or less than one year 
and did not find any effect on blood lipids and li-
poproteins (21-24). However, the unfavourable or 
detrimental effect of supplementation that con-
tinued further than one year is still controversial 
(25-27).
Serum lipid is one of the major risk factors of CVD. 
The present study was designed to illustrate the 
possible effects of vitamin D supplementation with 
or without calcium and vitamin D with multiple 
micronutrients in subjects with hypovitaminosis 
D resulting from an exclusive indoor-working life-
style and limited or no outdoor activities. No sig-
nificant effects of supplementation for one year on 
any of the lipids were observed in any of the sup-
plemented groups. 
At baseline, we observed that serum HDL-C con-
centrations in the subjects were uniformly low 
(<1.0 mmol/L) in more than 80% of the subjects in 
different groups, and no significant changes were 
observed after one year of intervention, suggesting 
that vitamin D supplementation in recommended 
doses and with calcium or multiple micronutrients 
may have no influence on serum lipid and lipopro-
tein manipulation. 























Table 3. Percentages of subjects in randomly-assigned groups with serum lipid variables 
below and above predefined cutoffs (at baseline and after one year)
Serum lipid


















HDL-C <1.0 mmol/L 80.0 95.0 95.1 83.8 85.7 92.5 97.5 89.2
LDL-C >3.0 mmol/L 17.1 20.0 12.2 13.5 14.3 15.0 7.3 16.2
T-C >5.0 mmol/L 8.6 15 4.9 2.7 5.7 12.5 7.3 13.5
TAG >2.0 mmol/L 14.2 17.5 12.2 - 2.6 12.5 12.2 -
Ca=Calcium; HDL-C=High-density lipoprotein cholesterol; LDL-C=Low-density lipoprotein choles-
terol; MMN-Ca=Multiple micronutrients-Vitamin D-Calcium; TAG=Triacylglycerol; TC=Total cholester-
ol; VD=Vitamin D; VD-Ca=Vitamin D-Calcium
Islam MZ et al.Vitamin D, calcium and multiple micronutrients supplementation on lipid profile
Volume 32 | Number 4 | December 2014 693
In fact, the present study was designed to exam-
ine the effect of vitamin D supplementation on 
skeletal health. Thus, the power was calculated 
with regard to the change in bone mineral con-
tent (12). Second, the doses given may have been 
sufficient for maintaining skeletal health but may 
have been insufficient for optimal effects on other 
health outcomes, like lipid profile. Recent reports 
suggested 2,000 IU to 10,000 IU of vitamin D per 
day as the safe doses and to have significant pub-
lic health implications. The minimal target level 
of serum 25OHD should be above 75 nmol/L but 
90-120 nmol/L could be favourable for optimal ef-
fects on health outcomes (28-30). We, therefore, 
believe that the result could have been different 
had we calculated the power for changes in serum 
lipids or used higher doses of vitamin D. A signifi-
cant change was observed in serum 25OHD con-
centration after one year of intervention (Figure 2), 
although the mean values were much lower than 
the suggested minimal target level (≥75 nmol/L) 
for multiple health outcomes. 
Limitations
The findings could not be generalized for Bangla-
deshi women, even for all the female garment fac-
tory workers of Bangladesh, although the social 
















Figure 3. Negative correlation between changes in serum iPTH and HDL cholesterol levels
ment factory workers may not differ significantly. 
However, results could be more representative by 
inclusion of subjects from different garment facto-
ries in Dhaka city and women from different so-
cioeconomic status, or a post-menopausal group 
as the post-menopausal influences in serum lipid 
profiles might be associated with increased risk of 
coronary heart disease. Results could have been dif-
ferent if different doses of vitamin D supplement 
were used. In addition, due to some technical limi-
tations, we could not measure dietary vitamin D 
intake and blood pressure in the subjects, which 
could add weight to the study.
Conclusions
The recommended dietary intake of 10 µg of vita-
min D/day with calcium or multiple micronutri-
ents for one year may have no influence on serum 
lipid profile. The long-term supplementation of vi-
tamin D and its adverse effect remain unclear and 
debatable. Therefore, longer-term clinical trial is 
warranted in evaluating the effect of intervention. 
Second, the present study indicated that recom-
mended dose of dietary vitamin D intake (10 µg/
day) might be not sufficient for young female gar-
ment factory workers with hypovitaminosis D to 
maintain adequate vitamin D status (serum 25- 
hydroxyvitamin D level >75 nmol/L).
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